You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Observer-blind

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Monkeypox Trial (BNT166a, BNT166c)

Not yet recruiting
  • Monkeypox
  • BNT166a
  • BNT166c
  • (no location specified)
Aug 4, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

COVID-19 Trial in Thái Bình (COVIVAC vaccine)

Completed
  • COVID-19
  • COVIVAC vaccine
  • Thái Bình, Thai Binh, Vietnam
    District Health Center of Vu Thu District
Jul 12, 2023

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Jan 18, 2023

Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)

Not yet recruiting
  • Influenza, Human
  • Investigational aQIVc
  • +2 more
  • (no location specified)
Aug 28, 2023

Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

Not yet recruiting
  • Herpes Zoster
  • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
  • +5 more
  • Halifax, Canada
    Canadian Center for Vaccinology
Aug 6, 2023

COVID-19 Trial in Newport Beach (hAd5-S-Fusion+N-ETSD, Placebo (0.9% (w/v) saline))

Completed
  • COVID-19
  • hAd5-S-Fusion+N-ETSD
  • Placebo (0.9% (w/v) saline)
  • Newport Beach, California
    Hoag Memorial Hospital Presbyterian
Sep 1, 2023

Poliomyelitis Trial in Geelong, Melbourne (Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio), Inactivated

Not yet recruiting
  • Poliomyelitis
  • Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
  • +3 more
  • Geelong, Victoria, Australia
  • +1 more
Oct 30, 2023

COVID-19 Trial in Manila (EuCorVac-19, ChAdOx1)

Recruiting
  • COVID-19
  • EuCorVac-19
  • ChAdOx1
  • Manila, Philippines
    Trial site
Oct 27, 2022

Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)

Not yet recruiting
  • Tuberculosis
  • BNT164a1
  • +2 more
  • (no location specified)
Sep 8, 2022

COVID-19 Trial in Kinshasa (EuCorVac-19, ChAdOx1)

Recruiting
  • COVID-19
  • EuCorVac-19
  • ChAdOx1
  • Kinshasa, Congo, The Democratic Republic of the
    Trial site
Nov 1, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Sumida-ku, Fukuoka (BNT162b2, Placebo)

Completed
Has Results
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • Placebo
  • Sumida-ku, Tokyo, Japan
  • +1 more
Jan 13, 2023

Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)

Not yet recruiting
  • Herpes Simplex
  • HSVTI Formulation 1
  • +2 more
  • Tokyo, Japan
    GSK Investigational Site
Aug 4, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Infection Trial (COVAC-1, Saline Placebo)

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  • COVAC-1
  • Saline Placebo
  • (no location specified)
Jan 23, 2023

Severe Acute Respiratory Syndrome Coronavirus 2 Trial (COVAC-2, Saline Placebo)

Not yet recruiting
  • Severe Acute Respiratory Syndrome Coronavirus 2
  • COVAC-2
  • Saline Placebo
  • (no location specified)
Aug 5, 2022

Local Anesthetic Trial (Chloroprocaine 3% eye gel, Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops)

Not yet recruiting
  • Local Anesthetic
  • Chloroprocaine 3% eye gel
  • Oxybuprocaine Hydrochloride 4 Mg/mL Eye Drops
  • (no location specified)
Jun 27, 2023

SARS-CoV-2 Infection Trial (PTX-COVID19-B, Vaxzevria®)

Not yet recruiting
  • SARS-CoV-2 Infection
  • PTX-COVID19-B
  • Vaxzevria®
  • (no location specified)
Sep 7, 2022

COVID-19 Trial in Natal, São Paulo, Rio De Janeiro (AstraZeneca/Fiocruz, Pfizer/Wyeth, Clover SCB-2019)

Not yet recruiting
  • COVID-19
  • AstraZeneca/Fiocruz
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +2 more
Jul 21, 2022

Functional Low-Vision Observer Rated Assessment for Profoundly

Suspended
  • Blindness, Acquired
    • Sylmar, California
      Second Sight Medical Products, Inc.
    Oct 31, 2022

    Influenza Trial in Ghent (TETRALITE)

    Active, not recruiting
    • Influenza
    • TETRALITE
    • Ghent, Belgium
      CEVAC, University Hospital
    Nov 16, 2022

    SARS-CoV-2 Infection, COVID-19 Trial (BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg, BNT162b4 5 µg, BNT162b4 10 µg)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • COVID-19
    • BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg
    • +3 more
    • (no location specified)
    Sep 14, 2022

    Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)

    Not yet recruiting
    • Cytomegalovirus Infection
    • mRNA-1647
    • Placebo
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 4, 2023

    Vaccine Reaction Trial in Cincinnati (Venezuelan Equine Encephalitis DNA Vaccine, PharmaJet Stratis Needle-free Injection

    Not yet recruiting
    • Vaccine Reaction
    • Venezuelan Equine Encephalitis DNA Vaccine
    • +2 more
    • Cincinnati, Ohio
      Velocity Clinical Research
    Aug 15, 2023

    l Device in Assistance of Detection and Diagnosis of Breast

    Completed
    • Breast Cancer
    • Mammography
    • Boston, Massachusetts
      Atrius Health
    Nov 9, 2022

    Covid19 Trial in Jakarta (SARS-CoV-2 Protein Subunit Recombinant Vaccine, SARS-CoV-2 Inactivated Vaccine)

    Completed
    • Covid19
    • SARS-CoV-2 Protein Subunit Recombinant Vaccine
    • SARS-CoV-2 Inactivated Vaccine
    • Jakarta, Greater Jakarta, Indonesia
      Fakultas Kedokteran Universitas Indonesia
    Aug 8, 2022